---
figid: PMC3138532__nihms251481f1
figtitle: HNSCC tumor microenvironment
organisms:
- NA
pmcid: PMC3138532
filename: nihms251481f1.jpg
figlink: /pmc/articles/PMC3138532/figure/F1/
number: F1
caption: HNSCC tumor microenvironment. This model depicts the potential signaling
  pathways for targeting in HNSCC, including ligands, receptors and signaling intermediates
  of the tumor cells and the contributing vascular endothelial cells and fibroblasts.
  Also shown are the molecular inhibitors currently in clinical investigation for
  the treatment of HNSCC. This model shows pathway convergence, pathway divergence
  and microenvironment signaling in order to demonstrate the potential of both single-targeting
  and multi-targeting drug approaches.
papertitle: The molecular pathogenesis of head and neck cancer.
reftext: Jonah D. Klein, et al. Cancer Biol Ther. ;9(1):1-7.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9342211
figid_alias: PMC3138532__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3138532__F1
ndex: bf99328b-deb0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3138532__nihms251481f1.html
  '@type': Dataset
  description: HNSCC tumor microenvironment. This model depicts the potential signaling
    pathways for targeting in HNSCC, including ligands, receptors and signaling intermediates
    of the tumor cells and the contributing vascular endothelial cells and fibroblasts.
    Also shown are the molecular inhibitors currently in clinical investigation for
    the treatment of HNSCC. This model shows pathway convergence, pathway divergence
    and microenvironment signaling in order to demonstrate the potential of both single-targeting
    and multi-targeting drug approaches.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - EGF
  - IGF1R
  - EGFR
  - IL6R
  - MET
  - GRB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - STAT3
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - KDR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - SRC
  - FGR
  - FYN
  - YES1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - Cediranib
  - Foretinib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
